Novo Nordisk
NVO
#22
Rank
S$536.88 B
Marketcap
$115.18
Share price
-17.83%
Change (1 day)
-16.09%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Cash on Hand

Cash on Hand as of September 2024 : S$15.20 Billion

According to Novo Nordisk's latest financial reports the company has S$15.20 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Novo Nordisk - Cash on Hand chart (from 1996 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31S$5.91 B29.92%
2022-12-31S$4.55 B26.46%
2021-12-31S$3.59 B29%
2020-12-31S$2.78 B-10.82%
2019-12-31S$3.12 B-4.43%
2018-12-31S$3.27 B-19.48%
2017-12-31S$4.06 B-4.17%
2016-12-31S$4.24 B-0.01%
2015-12-31S$4.24 B23.59%
2014-12-31S$3.43 B1.13%
2013-12-31S$3.39 B-2.81%
2012-12-31S$3.49 B-11.56%
2011-12-31S$3.94 B7.01%
2010-12-31S$3.68 B6.38%
2009-12-31S$3.46 B26.82%
2008-12-31S$2.73 B31.52%
2007-12-31S$2.07 B49.9%
2006-12-31S$1.38 B4.87%
2005-12-31S$1.32 B11.65%
2004-12-31S$1.18 B33.09%
2003-12-31S$0.89 B109.32%
2002-12-31S$0.42 B-46.48%
2001-12-31S$0.79 B155.37%
2000-12-31S$0.31 B4.4%
1999-12-31S$0.29 B61.08%
1998-12-31S$0.18 B-30.57%
1997-12-31S$0.26 B48.04%
1996-12-31S$0.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$13.48 B-11.28%๐Ÿ‡บ๐Ÿ‡ธ USA
S$4.76 B-68.63%๐Ÿ‡บ๐Ÿ‡ธ USA
S$10.96 B-27.84%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.87 B-35.06%๐Ÿ‡ซ๐Ÿ‡ท France